---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-022191"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:57:03.973760+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks Q1 revenue $38M (-53% YoY), plans $200M cost cuts, targets EBITDA breakeven by end 2026

## Summary
- Q1 total revenue $38M, down 53% YoY; Cell Engineering $28M (-18%), Biosecurity $10M.
- Loss from operations $178M (incl. $42M SBC); Adj. EBITDA -$100M, flat YoY; cash $840M, no debt.
- Restructuring: reduce annualized opex by $200M by mid-2025, cut labor >=25%, consolidate facilities up to 60%.
- Targeting adjusted EBITDA breakeven by end-2026; 2024 revenue guidance lowered to $170-190M.
- Added 17 new Cell Programs in Q1; expects at least 100 new customer projects in 2024.

## SEC filing metadata
- accession: 0001628280-24-022191
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828024022191/0001628280-24-022191-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828024022191/dna-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-022191
- JSON: https://secwatch.observer/filing/0001628280-24-022191.json
- Plain text: https://secwatch.observer/filing/0001628280-24-022191.txt

## Key facts
- Earnings Releases
  Ginkgo Bioworks Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $38 million.
  - Period: first quarter ended March 31, 2024
  - Revenue: $38 million
  - Result: reported results
  source text: First quarter 2024 Total revenue of $38 million, down from $81 million in the comparable prior year period
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000162828024022191/0001628280-24-022191-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.